BR9606648A - Produto de combinação composição farmacêutica e utilização - Google Patents

Produto de combinação composição farmacêutica e utilização

Info

Publication number
BR9606648A
BR9606648A BR9606648A BR9606648A BR9606648A BR 9606648 A BR9606648 A BR 9606648A BR 9606648 A BR9606648 A BR 9606648A BR 9606648 A BR9606648 A BR 9606648A BR 9606648 A BR9606648 A BR 9606648A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
combination product
product pharmaceutical
receptors
cells
Prior art date
Application number
BR9606648A
Other languages
English (en)
Other versions
BR9606648B1 (pt
Inventor
Serge Michel
Veronique Dionisius-Pouget
Original Assignee
Cird Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9482603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9606648(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cird Galderma filed Critical Cird Galderma
Publication of BR9606648A publication Critical patent/BR9606648A/pt
Publication of BR9606648B1 publication Critical patent/BR9606648B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI9606648-2A 1995-09-15 1996-09-10 produto de combinaÇço, composiÇço farmacÊutica e medicamento. BR9606648B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9510854A FR2738745B1 (fr) 1995-09-15 1995-09-15 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations
PCT/FR1996/001386 WO1997009987A1 (fr) 1995-09-15 1996-09-10 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide

Publications (2)

Publication Number Publication Date
BR9606648A true BR9606648A (pt) 1997-09-16
BR9606648B1 BR9606648B1 (pt) 2009-01-13

Family

ID=9482603

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9606648-2A BR9606648B1 (pt) 1995-09-15 1996-09-10 produto de combinaÇço, composiÇço farmacÊutica e medicamento.

Country Status (14)

Country Link
US (1) US6759396B1 (pt)
EP (1) EP0788361B1 (pt)
JP (1) JP2898100B2 (pt)
AT (1) ATE218349T1 (pt)
AU (1) AU687687B2 (pt)
BR (1) BR9606648B1 (pt)
CA (1) CA2204437C (pt)
DE (1) DE69621580T2 (pt)
DK (1) DK0788361T3 (pt)
ES (1) ES2181908T3 (pt)
FR (1) FR2738745B1 (pt)
NZ (1) NZ318430A (pt)
PT (1) PT788361E (pt)
WO (1) WO1997009987A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) * 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US20010002396A1 (en) 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
US6552009B2 (en) 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
FR2804323B1 (fr) 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
DE10255861A1 (de) * 2002-11-29 2004-06-17 Axxima Pharmaceuticals Ag Gegen Hepatitis C-Virusinfektionen nützliche Verbindungen und Substanzen
JP4473491B2 (ja) * 2002-05-28 2010-06-02 株式会社資生堂 毛穴縮小剤
US7595345B2 (en) * 2003-11-20 2009-09-29 Eli Lilly And Company Vitamin D receptor modulators
US7750184B2 (en) * 2003-11-20 2010-07-06 Eli Lilly And Company Vitamin D receptor modulators
WO2005102296A2 (en) * 2004-04-23 2005-11-03 Heptagen Limited Combinations for the treatment of immunoproliferative skin disorders such as psoriasis
PL1771180T5 (pl) * 2004-06-17 2011-04-29 Galderma Sa Kompozycja w postaci sprayu zawierająca kombinację propionianu klobetazolu i kalcytriolu, fazę alkoholową i fazę olejową
FR2871695B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
JP2008502647A (ja) * 2004-06-17 2008-01-31 ガルデルマ・ソシエテ・アノニム シリコーン剤、コルチコステロイドおよびビタミンｄまたはその誘導体を含む乾癬治療用組成物
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
WO2005123090A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
WO2006133829A2 (de) * 2005-06-17 2006-12-21 Dsm Ip Assets B.V. Verwendung von 25-hydroxy-vitamin d3
US20100056644A1 (en) * 2006-11-29 2010-03-04 Nilendu Sen Pharmaceutical compositions containing anhydrous calcipotriene
CN103202821B (zh) * 2013-04-09 2014-10-01 青岛正大海尔制药有限公司 一种骨化三醇软胶囊及其制备方法
WO2017074982A1 (en) 2015-10-30 2017-05-04 Patagonia Pharmaceuticals, Llc Isotretinoin formulations and uses and methods thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
FR2713635B1 (fr) 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2713640B1 (fr) * 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique

Also Published As

Publication number Publication date
WO1997009987A1 (fr) 1997-03-20
DE69621580T2 (de) 2003-03-13
FR2738745B1 (fr) 1997-10-24
AU6991296A (en) 1997-04-01
ATE218349T1 (de) 2002-06-15
BR9606648B1 (pt) 2009-01-13
AU687687B2 (en) 1998-02-26
JPH10503533A (ja) 1998-03-31
PT788361E (pt) 2002-11-29
CA2204437C (fr) 2003-06-10
CA2204437A1 (fr) 1997-03-20
DE69621580D1 (de) 2002-07-11
ES2181908T3 (es) 2003-03-01
EP0788361B1 (fr) 2002-06-05
EP0788361A1 (fr) 1997-08-13
MX9703461A (es) 1997-07-31
DK0788361T3 (da) 2002-07-15
FR2738745A1 (fr) 1997-03-21
JP2898100B2 (ja) 1999-05-31
US6759396B1 (en) 2004-07-06
NZ318430A (en) 2000-09-29

Similar Documents

Publication Publication Date Title
BR9606648A (pt) Produto de combinação composição farmacêutica e utilização
FI102142B (fi) Kosmeettinen koostumus, joka käsittää vähintään yhtä aktiivista ainett a sisältäviä, polymeerista tai rasvasta valmistettuja mikropalloja
BR9809465A (pt) Composições de cuidados com a pele e método para melhorar a aparência da pele
FR2710264B1 (fr) Utilisation pour le traitement des peaux mixtes d'une quantité efficace de substances actives.
PT1131039E (pt) Utilizacao de uma substancia que se liga ao receptor periferico das benzodiazepinas no tratamento de stresses cutaneos
ATE209477T1 (de) Minoxidil enthaltendes haarpflegemittel mit einem niedrigen gehalt an fettigem lösungsmittel
DE69503179T2 (de) Kosmetische und/oder dermatologische Zusammensetzung, die ein Tri (alpha-hydroxyacylat) von glycerin als einzigen Glycerinprecursor enthält
SE9303481L (sv) Hygienkomposition
FR2755965B1 (fr) Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
DE69419981T2 (de) Retinoid enthaltendes Mittel
ATE303127T1 (de) Verwendung von mindestens einem irvingia gabonensis-extrakt in kosmetischen und/oder pharmazeutischen produkten
ATE401855T1 (de) Stabile hautbehandlungsmittel enthaltend ein retinoid und ein retinoid-boostersystem
WO1998038968A3 (de) Kosmetisches körperpflegepräparat das honig enthält und verfahren zu seiner herstellung
ATE77048T1 (de) Bioemulgatoren enthaltende kosmetische und pharmazeutische zusammensetzungen.
ATE168988T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
ES2121463T3 (es) Uso de procisteina como agente blanqueante de la piel.
Morelli et al. Contact dermatitis due to benzoyl peroxide.
EP0968707A3 (de) Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
ATE213621T1 (de) Kosmetische mittel
KR890006806A (ko) 약쑥(애엽)분말이 함유된 피부보호 미용 비누 제조 방법
WO2004024106A3 (de) Verwendung eines ureahaltigen kosmetischen pflegemittels und ureahaltiges kosmetisches pflegemittel
RU94008830A (ru) Основа для косметических средств
KR900001360A (ko) 분말 제조특허(맥반석분말)
ITCA930003A1 (it) Prodotto dermatologico per uso topico, relativo processo di produzione ed ulizzazione terapeutica nelle ustioni e patologie cutanee.

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 31/19, A61K 31/192, A61K 31/59, A61K 31/592, A61K 31/593, A91P 17/00, A61P 17/06, A61P 17/10, A61P 17/12

Ipc: A61K 31/19, A61K 31/192, A61K 31/39, A61K 31/592,

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/04/2009, OBSERVADAS AS CONDICOES LEGAIS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.68489/2013 ORIGEM: JUIZO DA 001A VARA FEDERAL DE SAO PAULO PROCESSO NO 0017575-93.2013.4.03.6100 ACAO DE NULIDADE DE PATENTE AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: GENENTECH, INC., CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, PELE NOVA BIOTECNOLOGIA S/A E UNILEVER N.V.

B21B Extinction acc. art. 78, item ii - on waiver by the patentee, without prejudice to the rights of third parties

Free format text: SOLICITADA ATRAVES DA PETICAO 18130036473 (SP), DE 04/11/2013